Track 16: Coronary Artery Disease (CAD)


5th World Cardiology and Cardiovascular Diseases Conference

Dubai, UAE | March 04–06, 2026

Coronary Artery Disease (CAD) continues to be the leading cause of morbidity and mortality worldwide, posing a significant challenge to healthcare systems and professionals alike. Characterized by the narrowing or blockage of coronary arteries due to plaque buildup (atherosclerosis), CAD not only impacts millions of lives but also places a heavy burden on families and global economies.

At the 5th World Cardiology and Cardiovascular Diseases Conference in Dubai, Track 16: Coronary Artery Disease will provide a platform to discuss the latest advances in prevention, diagnosis, treatment, and rehabilitation for CAD patients.

Why This Track Matters

With changing lifestyles, increasing rates of diabetes, hypertension, obesity, and sedentary behavior, the prevalence of CAD is rising, particularly in younger populations. This track will focus on:

  • Early Detection & Risk Assessment – Screening strategies, imaging, biomarkers, and genetic predispositions.
  • Medical & Interventional Management – Statins, antiplatelet therapies, angioplasty, stenting, and bypass surgery.
  • Innovations in CAD Treatment – Precision medicine, drug-eluting stents, bioresorbable scaffolds, and advanced revascularization techniques.
  • Rehabilitation & Lifestyle Medicine – Nutrition, exercise, smoking cessation, and cardiac rehabilitation programs.
  • Global Health Perspectives – Tackling CAD challenges in both developed and developing regions.

Who Should Attend This Track?

This session is designed for:

  • Cardiologists & Interventional Cardiologists
  • Cardiac Surgeons
  • Internal Medicine Specialists & General Physicians
  • Clinical Researchers & Scientists
  • Nurses, Rehabilitation Experts & Allied Health Professionals
  • Pharmaceutical & Medical Device Industry Leaders

Why Attend in Dubai?

This track is more than just an academic discussion—it’s a global forum for knowledge exchange and collaboration. Delegates will explore how cutting-edge technologies, multidisciplinary care, and preventive strategies can transform outcomes for CAD patients.

Set against the vibrant backdrop of Dubai, UAE, this conference offers an extraordinary opportunity to network with world-renowned cardiology experts, foster collaborations, and stay at the forefront of cardiovascular medicine.

Don’t miss the chance to be part of this transformative dialogue on Coronary Artery Disease at the 5th World Cardiology and Cardiovascular Diseases Conference, taking place from March 04–06, 2026.

 

Comments

Post a Comment

Popular posts from this blog

Track 5: Cardio-Oncology – Where Cancer Care Meets Cardiovascular Precision

Image
5th World Cardiology and Cardiovascular Diseases Conference | March 04–06, 2026 | Dubai, UAE As cancer survival rates continue to rise, so too does a growing and urgent need to address the cardiovascular side effects of cancer therapies . At the intersection of oncology and cardiology lies the rapidly evolving field of Cardio-Oncology —the focus of Track 5 at the upcoming 5th World Cardiology and Cardiovascular Diseases Conference in Dubai, UAE . This dedicated track offers a critical platform to explore how cancer treatments impact the heart, and how healthcare professionals can work together to protect both survival and quality of life for patients. The Rising Relevance of Cardio-Oncology Life-saving cancer treatments such as chemotherapy, immunotherapy, radiation, and targeted agents often come with unintended cardiovascular risks—ranging from arrhythmias and hypertension to heart failure and myocardial ischemia. With the number of cancer survivors growing worldwide,...
Read more

Track 20: Diabetic Cardiomyopathy

Image
Track 20: Diabetic Cardiomyopathy 5th World Cardiology and Cardiovascular Diseases Conference Dubai, UAE | March 04–06, 2026 Diabetic cardiomyopathy (DCM) is a growing global concern that highlights the intricate link between diabetes and cardiovascular health . Characterized by structural and functional changes in the heart muscle in patients with diabetes—independent of coronary artery disease or hypertension—DCM is emerging as a major contributor to heart failure in diabetic populations. At the 5th World Cardiology and Cardiovascular Diseases Conference in Dubai , Track 20: Diabetic Cardiomyopathy will delve into the pathophysiology, diagnostic strategies, and therapeutic approaches to tackle this complex condition. With the rapid increase in diabetes worldwide, understanding and managing DCM is more critical than ever. Key Topics of Discussion Molecular Mechanisms – Hyperglycemia, oxidative stress, and myocardial fibrosis in DCM. Diagnosis & Imaging – The role of ech...
Read more

Track 22: Cardiac Devices and Diagnostics

Image
5th World Cardiology and Cardiovascular Diseases Conference Dubai, UAE | March 04–06, 2026 The field of cardiology has been transformed by innovative devices and advanced diagnostic technologies that enable earlier detection, more accurate monitoring, and more effective treatment of cardiovascular diseases. From wearable technologies and implantable devices to state-of-the-art imaging tools and AI-powered diagnostics , these advancements are revolutionizing patient outcomes and quality of life. At the 5th World Cardiology and Cardiovascular Diseases Conference in Dubai , Track 22: Cardiac Devices and Diagnostics will showcase the latest progress in medical devices, monitoring systems, imaging modalities, and diagnostic strategies that are shaping the future of cardiovascular care. Key Topics of Discussion Implantable Cardiac Devices – Pacemakers, defibrillators, and ventricular assist devices. Wearable & Remote Monitoring – Smartwatches, biose...
Read more